Esperion Therapeutics Inc (ESPR)
Retained Earnings
-$1.65B
Quarterly · Period ending: · USD
ESPR Retained Earnings
Latest reported-$1.65Bperiod ending
Latest reported-$1.65Bperiod ending
ESPR Quarterly Retained Earnings (-$17.51M → -$1.65B)
Quarterly retained earnings
High-resolution chart · PNG
ESPR retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -1,648,907,000 | |
| -1,623,711,000 | |
| -1,685,542,000 | |
| -1,654,209,000 | |
| -1,641,484,000 | |
| -1,601,029,000 | |
| -1,579,711,000 | |
| -1,550,187,000 | |
| -1,488,262,000 | |
| -1,549,284,000 | |
| -1,492,940,000 | |
| -1,451,690,000 | |
| -1,401,755,000 | |
| -1,340,036,000 | |
| -1,284,549,000 | |
| -1,229,432,000 | |
| -1,163,108,000 | |
| -1,106,377,000 | |
| -1,041,258,000 | |
| -971,872,000 | |
| -928,204,000 | |
| -838,817,000 | |
| -734,341,000 | |
| -648,904,000 | |
| -773,515,000 | |
| -695,266,000 | |
| -633,320,000 | |
| -564,943,000 | |
| -510,722,000 | |
| -598,101,000 | |
| -538,062,000 | |
| -488,151,000 | |
| -442,421,000 | |
| -396,291,000 | |
| -358,400,000 | |
| -313,181,000 | |
| -269,844,000 | |
| -229,200,000 | |
| -200,244,000 | |
| -182,842,000 | |
| -168,807,000 | |
| -154,222,000 | |
| -141,100,000 | |
| -128,299,000 | |
| -115,904,000 | |
| -104,438,000 | |
| -94,981,000 | |
| -85,175,000 | |
| -75,937,000 | |
| -68,063,158 | |
| -58,373,712 | |
| -53,135,278 | |
| -46,322,559 | |
| -41,975,025 | |
| -116,450,000 | |
| -109,887,000 | |
| -101,452,000 | |
| -94,046,000 | |
| -87,427,000 | |
| -80,447,000 | |
| -72,623,000 | |
| -65,320,000 | |
| -58,976,000 | |
| -52,695,000 | |
| -46,370,000 | |
| -40,389,000 | |
| -34,824,000 | |
| -24,020,000 | |
| -17,506,399 |